epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Aspruzyo Sprinkle
    ranolazine
  • remove Kapspargo Sprinkle
    metoprolol succinate

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Caution Advised

Smiley face Smiley face Aspruzyo Sprinkle (ranolazine) + Kapspargo Sprinkle (metoprolol succinate)

Caution Advised


ranolazine + metoprolol

caution advised: combo may incr. metoprolol levels, risk of hypotension, bradycardia, AV block, other adverse effects (hepatic metabolism inhibited)

Additional Considerations

Smiley face Smiley face metoprolol in Kapspargo Sprinkle

avoid combo with beverages or products containing ethanol and metoprolol extended-release (ER) sprinkle; combo may incr. metoprolol release rate, levels, risk of adverse effects, decr. duration of efficacy

Smiley face Smiley face ranolazine in Aspruzyo Sprinkle

avoid combo with beverages or products containing ethanol and ranolazine extended-release (ER) sprinkle; combo may incr. ranolazine release rate, levels, risk of adverse effects

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information